EQ

EQUILLIUM INC

EQ·29446K106·US·Common Stock·Healthcare - Biotechnology-13D/G

EQ (EQUILLIUM INC) is held by 36 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($13M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($10.7M), Woodline Partners LP ($7M). Net institutional sentiment: Bullish.

36
Holders
Avg rating(2 Elite)
$57.1M
Total Value
69% (38)
Fund Consensus
22 buying - 10 selling
EQSmart Money Verdict
View all
Held by 36 funds
2 elite
Who's Trading
InsiderCSConnelly StephenSell $91KJun 5, 2026
InsiderZCZedelmayer ChristineSell $43KJun 5, 2026
InsiderCSConnelly StephenSell $633KJun 4, 2026
InsiderTPTom PennySell $192KMay 28, 2026
ActivistXCXiangmin Cui8.9%May 15, 2026
ActivistADADAR1 Capital Management, LLC9.9%May 15, 2026
ActivistAberdeen Group plcAberdeen Group plc5.3%May 7, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.9.9%Mar 20, 2026
InsiderZCZedelmayer ChristineSell $301KMar 13, 2026
InsiderZCZedelmayer ChristineSell $362KMar 9, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
6.5M(+10.8%)$13M0.0%+85.19%
31
Unchanged
5.3M$10.7M0.0%+99.32%
0
Unchanged
3.5M$7M0.0%+99.32%
0
Increased
3.4M(+41.7%)$6.7M0.0%+81.36%
36
New
3.1M$6.2M0.1%+64.41%
38
New
1.8M$3.6M0.0%+64.41%
37
Decreased
1.6M(-21.1%)$3.3M0.0%+98.89%
0
Decreased
656,964(-10.4%)$1.3M0.0%+141.09%
0
Unchanged
428,538$857,0760.0%+95.11%
0
Increased
378,813(+9.7%)$757,9750.0%-8.91%
18
Decreased
262,643(-53.3%)$525,2860.0%+96.36%
0
Decreased
246,173(-24.2%)$492,3460.0%+92.32%
0
Increased
221,241(+119.4%)$442,4820.0%+74.28%
39
New
189,530$379,0600.0%+64.41%
33
Increased
174,060(+12.0%)$348,1200.0%+133.30%
18
New
158,733$317,4660.0%+64.41%
33
Increased
127,852(+1.4%)$255,7040.0%+98.72%
16
Decreased
115,535(-37.8%)$231,0700.0%+87.74%
0
New
103,105$206,2100.0%+64.41%
32
Decreased
70,158(-20.8%)$140,3160.0%-7.78%
0

Showing 1-20 of 38

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used